JP2007505114A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505114A5
JP2007505114A5 JP2006526121A JP2006526121A JP2007505114A5 JP 2007505114 A5 JP2007505114 A5 JP 2007505114A5 JP 2006526121 A JP2006526121 A JP 2006526121A JP 2006526121 A JP2006526121 A JP 2006526121A JP 2007505114 A5 JP2007505114 A5 JP 2007505114A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
trifluoromethyl
alkoxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526121A
Other languages
English (en)
Japanese (ja)
Other versions
JP4897484B2 (ja
JP2007505114A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/027533 external-priority patent/WO2005034850A2/en
Publication of JP2007505114A publication Critical patent/JP2007505114A/ja
Publication of JP2007505114A5 publication Critical patent/JP2007505114A5/ja
Application granted granted Critical
Publication of JP4897484B2 publication Critical patent/JP4897484B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006526121A 2003-09-11 2004-08-24 C型肝炎ウイルスを治療するためのシクロアルキル複素環化合物 Expired - Fee Related JP4897484B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50206703P 2003-09-11 2003-09-11
US60/502,067 2003-09-11
PCT/US2004/027533 WO2005034850A2 (en) 2003-09-11 2004-08-24 Cycloalkyl heterocycles for treating hepatitis c virus

Publications (3)

Publication Number Publication Date
JP2007505114A JP2007505114A (ja) 2007-03-08
JP2007505114A5 true JP2007505114A5 (cg-RX-API-DMAC10.html) 2007-10-11
JP4897484B2 JP4897484B2 (ja) 2012-03-14

Family

ID=34434839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526121A Expired - Fee Related JP4897484B2 (ja) 2003-09-11 2004-08-24 C型肝炎ウイルスを治療するためのシクロアルキル複素環化合物

Country Status (7)

Country Link
US (1) US7112601B2 (cg-RX-API-DMAC10.html)
EP (1) EP1663105B1 (cg-RX-API-DMAC10.html)
JP (1) JP4897484B2 (cg-RX-API-DMAC10.html)
AT (1) ATE498398T1 (cg-RX-API-DMAC10.html)
DE (1) DE602004031435D1 (cg-RX-API-DMAC10.html)
ES (1) ES2358904T3 (cg-RX-API-DMAC10.html)
WO (1) WO2005034850A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502258B1 (de) * 2005-07-22 2007-09-15 Univ Wien Cox-i-inhibitorverbindungen
US20070032488A1 (en) * 2005-08-05 2007-02-08 Genelabs Technologies, Inc. 6-Membered aryl and heteroaryl derivatives for treating viruses
WO2008019477A1 (en) * 2006-08-17 2008-02-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2008106166A2 (en) * 2007-02-28 2008-09-04 Conatus Pharmaceuticals, Inc. Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors
WO2008106167A1 (en) * 2007-02-28 2008-09-04 Conatus Pharmaceuticals, Inc. Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
EP2193807A4 (en) 2007-08-24 2012-09-12 Univ Sapporo Medical CYCLOSPORIN A-BINDING PROTEIN
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
KR20110116136A (ko) 2009-01-07 2011-10-25 싸이넥시스, 인크. Hcv 및 hiv 감염의 치료에 사용하기 위한 사이클로스포린 유도체
KR20140003521A (ko) 2010-12-30 2014-01-09 이난타 파마슈티칼스, 인코포레이티드 페난트리딘 매크로사이클릭 c형 간염 세린 프로테아제 억제제
CN103534256B (zh) 2010-12-30 2016-08-10 益安药业 大环丙型肝炎丝氨酸蛋白酶抑制剂
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
WO2019169193A1 (en) 2018-03-01 2019-09-06 Annapurna Bio Inc. Compounds and compositions for treating conditions associated with apj receptor activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9611047A (pt) * 1995-10-17 2000-03-08 Searle & Co Processo de deteção de ciclo oxigenase-2
CA2338490A1 (en) 1998-07-27 2000-02-10 Sergio Altamura Diketoacid-derivatives as inhibitors of polymerases
IL141456A0 (en) 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
WO2000013708A1 (en) 1998-09-04 2000-03-16 Viropharma Incorporated Methods for treating or preventing viral infections and associated diseases
BR9913935A (pt) 1998-09-25 2001-06-19 Viropharma Inc Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
AU1324300A (en) * 1998-10-26 2000-05-15 Vertex Pharmaceuticals Incorporated Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase
CA2389745C (en) 1999-11-04 2010-03-23 Shire Biochem Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
CZ20013424A3 (cs) 1999-12-27 2002-02-13 Japan Tobacco Inc. Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP1256628A3 (en) 2001-05-10 2003-03-19 Agouron Pharmaceuticals, Inc. Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
EP2363396A1 (en) 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CA2448737C (en) 2001-07-20 2010-06-01 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US20030134853A1 (en) * 2001-09-26 2003-07-17 Priestley Eldon Scott Compounds useful for treating hepatitis C virus

Similar Documents

Publication Publication Date Title
JP2007508359A5 (cg-RX-API-DMAC10.html)
JP2024521920A5 (cg-RX-API-DMAC10.html)
RU2386622C2 (ru) Гетероароматические производные мочевины и их применение в качестве активаторов глюкокиназы
JP2005523310A5 (cg-RX-API-DMAC10.html)
JP2006508935A5 (cg-RX-API-DMAC10.html)
WO2009010660A3 (fr) Indazoles substitues, leur preparation et leur utilisation en therapeutique
JP2007519618A5 (cg-RX-API-DMAC10.html)
JP2006500348A5 (cg-RX-API-DMAC10.html)
JP2010504286A5 (cg-RX-API-DMAC10.html)
IL185844A0 (en) I-acetic acid-indole derivatives with pgd2 antagonist activity
JP2009534471A5 (cg-RX-API-DMAC10.html)
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
JP2007518682A5 (cg-RX-API-DMAC10.html)
IL189069A0 (en) Piperidine and piperazine derivatives as p2x3 antagonists
RU2007134383A (ru) Производные 1,5-диарилпиррола, их получение и применение в терапии
JP2006528646A5 (cg-RX-API-DMAC10.html)
WO2001046144A8 (en) New modulators of dopamine neurotransmission
WO2008087611A3 (en) Pyrrolidine- and piperidine- bis-amide derivatives
JP2012514020A5 (cg-RX-API-DMAC10.html)
JP2011512412A5 (cg-RX-API-DMAC10.html)
JP2005517643A5 (cg-RX-API-DMAC10.html)
ATE443701T1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
JP2008520637A5 (cg-RX-API-DMAC10.html)
WO2002064567A3 (en) Substituted carboxamides as inhibitors of factor xa